The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

1. They came in prepared this time, with outrageous and lawless executive orders written and ready to roll out. 2. When Trump ...

Nissan Motor plans to procure batteries for electric vehicles sold in the U.S. from South Korea's SK On from around 2028 ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...